Literature DB >> 11064772

A comparison of the efficacy of cefuroxime axetil and intramuscular benzathine penicillin for treating streptococcal tonsillopharyngitis.

S Uysal1, R Sancak, M Sunbul.   

Abstract

Throat cultures were performed on 297 children suspected of tonsillopharyngitis on clinical findings. Group A beta-haemolytic streptococci (GABHS) were isolated from 86 patients (41 males/45 females) aged 6-15 (mean (SD) 7.8 (0.04)) years. They were randomly allocated to receive oral cefuroxime axetil for 10 days (group 1) or one dose of benzathine penicillin by intramuscular injection (group 2) and responses were evaluated 2 weeks later. Clinical cure was observed in 95% of group 1 and 96% of group 2 and bacteriological cure in 86 and 84% of groups 1 and 2, respectively. Our results show that intramuscular benzathine penicillin remains an effective treatment for GABHS and that oral cefuroxime axetil is also effective.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064772     DOI: 10.1080/02724936.2000.11748134

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  4 in total

Review 1.  Short-course antimicrobial therapy of respiratory tract infections.

Authors:  David Guay
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Different antibiotic treatments for group A streptococcal pharyngitis.

Authors:  Mieke L van Driel; An Im De Sutter; Hilde Habraken; Sarah Thorning; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2016-09-11

3.  Treatment outcomes of acute streptococcal tonsillitis according to antibiotic treatment. A retrospective analysis of 242,366 cases treated in the community.

Authors:  Mattan Bar-Yishay; Ilan Yehoshua; Avital Bilitzky; Yan Press
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

4.  Different antibiotic treatments for group A streptococcal pharyngitis.

Authors:  Mieke L van Driel; An Im De Sutter; Sarah Thorning; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.